MREO
HEALTHCAREMereo BioPharma Group PLC ADR
AI Insight
What's Moving MREO Today?
No stock-specific AI insight has been generated for MREO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.20$3.05
$0.32
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-0.20
Dividend Yield—
Dividend / Share—
ROE-75.9%
Profit Margin—
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding159.6M
MREO News
27 articles- European Equities Traded in the US as American Depositary Receipts Rise in Wednesday TradingYahoo Finance·Jun 17, 2026
- European Equities Traded in the US as American Depositary Receipts Surge in Monday TradingYahoo Finance·Jun 15, 2026
- European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for WeekYahoo Finance·Jun 12, 2026
- European Equities Traded in US as ADRs Rise in Thursday TradingYahoo Finance·Jun 11, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday TradingYahoo Finance·Jun 8, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday TradingYahoo Finance·Jun 3, 2026
- Mereo BioPharma : to Participate in Fireside Chat at the Jefferies Global Healthcare Conference 2026www.marketscreener.com·Jun 3, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingYahoo Finance·Jun 2, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Monday TradingYahoo Finance·Jun 1, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for WeekYahoo Finance·May 29, 2026
- European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday TradingYahoo Finance·May 26, 2026
- European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday TradingYahoo Finance·May 22, 2026
- European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday TradingYahoo Finance·May 18, 2026
- EcoR1, Oleg Nodelman report 8.4% stake in Mereo (MREO)Stock Titan·May 15, 2026
- European Equities Traded in the US as American Depositary Receipts Flat in Wednesday TradingYahoo Finance·May 13, 2026
- European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday TradingYahoo Finance·May 12, 2026
- Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate UpdatesYahoo Finance·May 12, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·May 11, 2026
- European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday TradingYahoo Finance·May 6, 2026
- European Equities Traded in the US as American Depositary Receipts Higher in Tuesday TradingYahoo Finance·May 5, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Apr 30, 2026
- European Equities Traded in the US as American Depositary Receipts Lower in Wednesday TradingYahoo Finance·Apr 29, 2026
- ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNOGlobeNewswire Inc.·Apr 3, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc.·Apr 3, 2026
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREOGlobeNewswire Inc.·Mar 31, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc.·Mar 27, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc.·Mar 24, 2026
All 27 articles loaded
Price Data
Open$0.32
Previous Close$0.33
Day High$0.34
Day Low$0.32
52 Week High$3.05
52 Week Low$0.20
52-Week Range
$0.20$3.05
$0.32
Fundamentals
Market Cap$52M
P/E Ratio—
EPS$-0.20
Dividend Yield—
Dividend / Share—
ROE-75.9%
Profit Margin—
Debt / Equity—
Trading
Volume1.6M
Avg Volume (10D)—
Shares Outstanding159.6M
About Mereo BioPharma Group PLC ADR
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases in the UK and internationally. The company is headquartered in London, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—